Skip to main content
. 2022 Mar 4;9:792577. doi: 10.3389/fnut.2022.792577

Table 3.

Basic clinical information of E-DM vs. non-DM patients.

Parameters Lung Cancer Digestive tract Cancer Liver Cancer Leukemia Breast Cancer Others
(N = 898) (N = 598) (N = 177) (N = 315) (N = 701) (N = 240)
Non-DM E-DM P Non-DM E-DM P Non-DM E-DM P Non-DM E-DM P Non-DM E-DM P Non-DM E-DM P
NRS2002 0.64 1.07 0.004 0.85 0.71 0.513 0.67 0.92 0.478 0.29 0.80 0.069 0.21 0.64 0.001 0.75 0.57 0.540
KPS 89.41 88.85 0.636 86.63 86.88 0.901 88.82 85.00 0.254 89.79 87.14 0.341 91.97 91.72 0.877 89.01 88.70 0.899
TP (g/L) 67.78 66.99 0.345 64.16 66.18 0.072 65.38 64.29 0.607 64.17 56.00 <0.001 69.13 69.65 0.625 68.02 69.03 0.521
Albumin (g/L) 39.26 38.29 0.114 37.23 37.59 0.652 36.90 34.89 0.191 37.81 33.76 0.004 41.74 41.02 0.348 39.47 38.64 0.475
PAB (g/L) 0.21 0.21 0.529 0.19 0.18 0.465 0.18 0.15 0.270 0.22 0.18 0.127 0.23 0.22 0.251 0.21 0.18 0.092
TFN (g/L) 4.19 2.08 0.748 2.42 2.39 0.910 2.33 2.20 0.577 2.49 2.40 0.891 2.72 2.58 0.738 2.37 2.27 0.649
CRP (mg/L) 15.16 17.41 0.618 23.40 23.26 0.983 12.18 9.08 0.774 10.21 5.63 0.321 5.80 12.00 0.246 26.66 17.36 0.579
Height (cm) 1.66 1.64 0.098 1.67 1.66 0.453 1.66 1.63 0.097 1.67 1.69 0.250 1.59 1.57 0.140 1.61 1.61 0.949
Weight (kg) 63.81 62.69 0.457 61.79 63.39 0.362 63.52 60.01 0.240 64.87 64.48 0.907 62.87 60.42 0.185 60.77 61.03 0.907
BMI
(kg/m2)
23.12 23.14 0.963 22.16 22.97 0.128 22.89 22.66 0.785 23.30 22.49 0.406 24.91 24.38 0.435 23.37 23.48 0.881
HGS (kg) 26.32 24.27 0.119 26.00 24.12 0.203 27.04 18.02 0.003 25.61 24.21 0.622 20.38 17.33 0.008 21.21 19.64 0.363
VFA (cm2) 90.22 94.22 0.384 79.45 84.93 0.319 85.69 83.10 0.788 78.07 79.29 0.891 100.28 99.47 0.901 91.25 88.44 0.710
NLR 3.23 4.31 0.014 4.34 9.06 0.017 4.15 4.50 0.822 2.89 2.73 0.892 2.22 3.40 <0.001 3.88 2.85 0.047
PLR 171.69 182.99 0.529 179.75 234.08 0.032 147.52 210.40 0.051 174.68 194.66 0.727 146.10 183.39 0.011 188.47 178.58 0.775

DM, diabetes mellitus; E-DM, euglycemia diabetes mellitus; NRS-2002, the nutritional risk screening-2002 score; KPS, karnofsky performance status; TP, total protein; PAB, prealbumin; TFN, transferrin; CRP, C-reaction protein; BMI, body mass index; NLR, neutrophil to lymphocyte ratio; PLR, platelets to lymphocyte ratio; HGS, hand-grip strength; VFA: visceral fat area.